Novo Nordisk Inks Obesity-Related R&D Deals with Local Biotechs
- Posted by ISPE Boston
- On January 11, 2024
As the first two programs signed under its collaboration with Flagship Pioneering, Novo Nordisk has entered into separate research collaborations with Omega Therapeutics and Cellarity. The companies, both founded by Flagship Pioneering in 2017, are based in Cambridge and Somerville, respectively. The Omega collaboration will leverage its proprietary platform technology to develop a potential new […]
Read More